Press Releases

BUFFALO GROVE, Ill. & COPENHAGEN, Denmark--(BUSINESS WIRE)-- Xellia Pharmaceuticals (‘Xellia’), a global leader in the manufacturing of specialty anti-infective treatments, announced today it has launched Vancomycin Hydrochloride for Injection, USP within the United States market. “Today marks an important milestone for our US market strategy and represents a significant step fo

SEATTLE--(BUSINESS WIRE)-- Virence Health Technologies today announced Centricity™ EDI Services, Centricity Payer Connect, Hosted Client Metrics and DenialsIQ* have earned Certified status for information security by HITRUST. HITRUST Common Security Framework (CSF) Certified status demonstrates that the organization has met key regulatory requirements and industry-defined requirements and is ap

NEWBURY PARK, Calif.--(BUSINESS WIRE)-- Compulink Healthcare Solutions, the creator of Advantage SMART Practice™, an all-in-one EHR and practic

SAN DIEGO--(BUSINESS WIRE)-- Innovus Pharmaceuticals, Inc., (“Innovus Pharma”) (OTCQB: INNV), today announced preliminary third quarter 2018 net revenue is estimated to be between $7.0 million to $7.1 million or an approximate 215-219% increase from the third quarter of 2017. Innovus Pharma's third quarter 2018 anticipated revenue results are preliminary and based on the most current information ava

SAN DIEGO--(BUSINESS WIRE)-- Arima Genomics, Inc., a biotechnology company empowering researchers to apply long-range genetic sequence and structure information toward the understanding of health, disease and species evolution, announced today the full commercial launch of its Arima-HiC technology. The Arima-HiC sample preparation kit is a simple and rapid 6-hour protocol that enables detection of long-range ch

LONDON--(BUSINESS WIRE)-- Arthur D. Little (ADL) today published a new research report that highlights the impact digital technology such as AI, advanced analytics, self-learning systems and the Internet of Things will have on the innovation process. 93% of respondents in its global survey agreed that digital innovation will fully or partly transform their organization. Leaders will benefit from a 1.7x increase

McKINNEY, Texas--(BUSINESS WIRE)-- Soleo Health, an innovative leader in specialty infusion services, announced today it has been chosen by

ARCHAMPS, France--(BUSINESS WIRE)-- Regulatory News: Genkyotex (Paris:GKTX) (Brussels:GKTX) (Euronext Paris & Brussels: FR00011790542 – GKTX) announced today that its lead product candidate GKT831, a NOX1/4 inhibitor, met both the primary and secondary interim efficacy endpoints with high statistical significance after only 6 weeks of treatment. The data establish GKT831 as an attrac

LONDON & DOHA, Qatar--(BUSINESS WIRE)-- Today, STATS, the worldwide leader in sports data and intelligence, announced the extension of an exclusive performance partnership with the Qatar Stars League (QSL), providing a robust range of products for all 12 pro clubs and the league’s football development department, as well as marketing and communications. The partnership between the QSL and S

SOUTHBOROUGH, Mass.--(BUSINESS WIRE)-- Veristat, a full-service Clinical Research Organization (CRO), announced today that it has partnered with

NESS ZIONA, Israel--(BUSINESS WIRE)-- Foresight Autonomous Holdings Ltd. (NASDAQ:FRSX) (TASE:FRSX), an innovator in automotive vision systems, announced today that it has increased its stake in RailVision Ltd. by exercising warrants into 2,704 of RailVision’s ordinary shares for an aggregate of $0.6 million. The exercise follows RailVision’s successful participation at the InnoTrans Internati

HAYWARD, Calif. & PHILADELPHIA, Pa.--(BUSINESS WIRE)-- At the ISPE annual meeting today, Pharmatech Associates introduced Pharmatech Associates International Contracting and Services, LLC (PAICS), a new company with headquarters in Doha, Qatar. PAICS provides a global, single-source platform for clients and investors from which next-generation pharmaceutical

BOSTON--(BUSINESS WIRE)-- Gelesis, a biotechnology company developing first-in-class mechanotherapeutics to treat obesity and other chronic diseases related to the gastrointestinal

PARIS--(BUSINESS WIRE)-- Regulatory News: Onxeo S.A. (Euronext Paris, NASDAQ Copenhagen: ONXEO), a clinical-stage biotechnology company specializing in the development of innovative drugs in oncology targeting tumor DNA Damage Response (DDR) to fight resistant cancers, today announced positive interim results from the first three dose levels already evaluated out of six planned in

MARSEILLE, France--(BUSINESS WIRE)-- Traxens, a company providing high-valued data and services for the supply chain industry, and Daher, a leading logistics and service provider, today announce they have signed a commercial contract to monitor and track the fleet of sensitive equipment of Daher’s customers. Since 2016, the two companies have been collaborating and they are now entering a long-